Literature DB >> 395420

Experimental candida-induced arteritis in mice. Relation to arteritis in the mucocutaneous lymph node syndrome.

H Murata.   

Abstract

An extract of Candida albicans isolated from a patient with typical mucocutaneous lymph node syndrome (MCLS) can produce coronary arteritis in a mouse when injected intraperitoneally. An unusual feature of this arteritis is that it is granulomatous, shows no fibrinoid change and is confined to the coronary arteries. These characteristics are quite similar to those found in patients with MCLS.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 395420     DOI： 10.1111/j.1348-0421.1979.tb02815.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN： 0385-5600            Impact factor:   1.955


  13 in total

1.  Diagnostic potential of antibody titres against Candida cell wall β-glucan in Kawasaki disease.

Authors:  K Ishibashi; R Fukazawa; N N Miura; Y Adachi; S Ogawa; N Ohno
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

2.  Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.

Authors:  Henry S Su; Matthias Nahrendorf; Peter Panizzi; Michael O Breckwoldt; Elisenda Rodriguez; Yoshiko Iwamoto; Elena Aikawa; Ralph Weissleder; John W Chen
Journal:  Radiology       Date:  2011-11-14       Impact factor: 11.105

3.  Contribution of myeloperoxidase to coronary artery vasculitis associated with MPO-ANCA production.

Authors:  A Ishida-Okawara; T Oharaseki; K Takahashi; Y Hashimoto; Y Aratani; H Koyama; N Maeda; S Naoe; K Suzuki
Journal:  Inflammation       Date:  2001-12       Impact factor: 4.092

4.  Implications of hepatic dysfunction in Kawasaki disease: Time-related changes in aspartate aminotransferase, alanine aminotransferase, total bilirubin, and C-reactive protein levels.

Authors:  Yasuhiko Tomita; Takashi Fukaya; Yasuko Yamaura; Rie Tsujiguchi; Haruko Muratani; Maki Shimaya
Journal:  Pediatr Investig       Date:  2019-03-22

5.  Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis.

Authors:  I-Chun Lin; Ho-Chang Kuo; Ying-Jui Lin; Feng-Shen Wang; Lin Wang; Shun-Chen Huang; Shao-Ju Chien; Chien-Fu Huang; Chih-Lu Wang; Hong-Ren Yu; Rong-Fu Chen; Kuender D Yang
Journal:  PLoS One       Date:  2012-06-21       Impact factor: 3.240

6.  The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease.

Authors:  Akiko Hamaoka-Okamoto; Chinatsu Suzuki; Tomoyo Yahata; Kazuyuki Ikeda; Noriko Nagi-Miura; Naohito Ohno; Yoshinori Arai; Hideo Tanaka; Tetsuro Takamatsu; Kenji Hamaoka
Journal:  Pediatr Rheumatol Online J       Date:  2014-03-30       Impact factor: 3.054

Review 7.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

8.  A novel mouse model of coronary stenosis mimicking Kawasaki disease induced by Lactobacillus casei cell wall extract.

Authors:  Eisuke Suganuma; Satoshi Sato; Satoko Honda; Atsuko Nakazawa
Journal:  Exp Anim       Date:  2020-01-13

9.  Associations between the spatiotemporal distribution of Kawasaki disease and environmental factors: evidence supporting a multifactorial etiologic model.

Authors:  Brian W McCrindle; Cedric Manlhiot; Tisiana Low; Brigitte Mueller; Chun-Po S Fan; Emily Somerset; Sunita O'Shea; Leonard J S Tsuji; Hong Chen
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

Review 10.  Recent Advances in Kawasaki Disease.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.